DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Monami M, Nreu B, Scatena A. et al.
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials.
Diabetes Obes Metab 2017;
19 (09) 1233-1241
We do not assume any responsibility for the contents of the web pages of other providers.